For providers
Provider Login
Dr. Amarnath Challapalli

Dr. Amarnath Challapalli

Oncologist

Bristol, BS6 6UT

Verified profile
25 years of experience
Verified profile
25 years of experience

Patient Trust Score

New

--

Recent patient review

This specialist has no reviews at the moment.

Latest endorsement

This provider has no professional endorsements.

Call

Email

AboutFeesLocationReviewsFAQ

About

Dr. Amarnath Challapalli is a Consultant Clinical Oncologist at Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust. He specialises in the management of urological cancers (prostate, bladder, renal and penile cancers) and non-melanomatous skin cancer with radiotherapy, brachytherapy, chemotherapy and immunotherapy; in both NHS and private practice. He chairs the clinical governance committee at the Bristol Cancer Institute and is a member of the Medicines advisory group (MAG). He organises and lectures in the skin cancer study day for the Royal College of Radiologists and is a faculty member on other courses for the college; demonstrating his excellence and ongoing passion for his sub-speciality. He is also a panel member of Mirrors in Medicine, an International Case-based professional development platform. He has been chosen as a Prostate Cancer UK (PCUK) Clinical Champion and is leading on a project to improve access to PSMA PET scans and Lutetium based radioligand therapy.

Dr. Challapalli undertook his medical and postgraduate training in clinical oncology in India and in the UK, achieving Fellowship of the Royal College of Radiologists. He subsequently completed a PhD at Imperial College, London in January 2014; testament to his passion and dedication to medical research alongside his practice. His research focused on the translation of novel PET tracers looking at cell proliferation, apoptosis and choline metabolism into clinical studies to look at early response assessment to treatment. His work has been published in peer-reviewed journals and presented at national and international meetings.

His research interests include functional imaging for urological cancers, stereotactic radiotherapy, brachytherapy, image guidance and exploring chemotherapy & immunotherapy combinations. He has developed and leads the brachytherapy service for non-melanoma skin cancers at the Bristol Cancer Institute. He is the UK Chief Investigator for the adjuvant Cemiplimab trial in high risk squamous cell carcinoma (C-POST trial) and a Co-Chief Investigator of the national multicentre ACE trial in prostate cancer and EPIC trial in penile cancer.

Dr. Challapalli is one of the highly skilled multi-disciplinary team at GenesisCare Bristol where he sees private patients; using his knowledge and expertise to not only provide the best physical outcomes for patients but also make sure that each patient's individual cancer journey is tailored exactly to their needs.

Diseases, Medical Tests and Treatments

  • Radiotherapy (IMRT, VMAT, Stereotactic Radiotherapy(SABR))
  • Brachytherapy
  • Chemotherapy
  • Immunotherapy
  • Urological cancers
  • Non-melanomatous skin cancer

Subspecialties
  • Bladder Cancer
  • Clinical Oncology
  • Renal Cancer
  • Urological Oncology

All conditions and treatments
  • Bladder Cancer
  • Oligometastic Disease
  • Penile Cancer
  • Prostate Cancer
  • Renal (Kidney) Cancer
  • Renal Cancer
  • Skin Cancer
  • Urological Cancers
  • Brachytherapy
  • Chemotherapy
  • Clinical Trials
  • Hormone Therapy
  • Image Guided Radiotherapy (IGRT)
  • Immunotherapy
  • Intensity Modulated Radiotherapy (IMRT)
  • Radiotherapy
  • RapidArc or Volume Modulated Arc Therapy (VMAT)
  • Stereotactic Ablative Radiotherapy (SABR)

Registered with

General Medical Council

No. 6031215

The Royal College of Radiologists (RCR)

No. 311637


Qualifications
  • MBBS Osmania Medical College, Hyderabad, India 2000
  • MD (Radiotherapy) PGIMER, Chandigarh, India 2005
  • MRCP Royal College of Physicians, UK 2008
  • FRCR Royal College of Radiologists 2009
  • PhD Imperial College, London 2014

Memberships:

  • Royal College of Radiologists, London
  • British Uro-Oncology Group

languages spoken
  • English
  • Hindi
  • Telugu
consultation fees
  • New appointment: £250
  • Follow-up appointment: £150

insurers
  • Simply Health
  • Aetna
  • Vitality Health
  • Aviva Health
  • AXA PPP Healthcare
  • Healix
  • Bupa

Location

All locations

Spire Bristol Hospital

4.83
(99)
Redland Hill Durdham Down, Bristol, United Kingdom, BS6 6UT
Redland Hill Durdham Down, Bristol, United Kingdom, BS6 6UT
Monday
Not available
Tuesday
Not available
Wednesday
Not available
Thursday
Not available
Friday
Not available
Saturday
Not available
Sunday
Not available
4.71
(24)
300 Park Ave, Bristol, United Kingdom, BS32 4SY
300 Park Ave, Bristol, United Kingdom, BS32 4SY
Monday
Not available
Tuesday
Not available
Wednesday
Not available
Thursday
Not available
Friday
Not available
Saturday
Not available
Sunday
Not available
0
(0)
Southmead Road Westbury-on-Trym, Bristol, United Kingdom, BS10 5NB
Southmead Road Westbury-on-Trym, Bristol, United Kingdom, BS10 5NB
Monday
Not available
Tuesday
Not available
Wednesday
Not available
Thursday
Not available
Friday
Not available
Saturday
Not available
Sunday
Not available

Reviews

Amarnath Challapalli has not collected any reviews yet

Your trust is our top concern, so providers can't pay to alter or remove reviews.
Learn more here

FAQ

What languages does Dr. Amarnath Challapalli speak?

Dr. Amarnath Challapalli speaks English, Hindi and Telugu

Where is Dr. Amarnath Challapalli located?

Dr. Amarnath Challapalli primarily practices at Spire Bristol Hospital, located at Redland Hill Durdham Down, Bristol, United Kingdom, BS6 6UT
See more locations

Does Dr. Amarnath Challapalli accept new patients?

Dr. Amarnath Challapalli generally accepts new patients.

Get in touch with this specialist to enquire as a new patient